Biogen (BIIB) Upgraded to Buy at Credit Suisse Group

The stock was bought at an average cost of $317.36 per share, with a total value of $9,520,800.00. The institutional investor held 46,215 shares of the industrial machinery and components company at the end of 2017Q3, valued at $7.77 million, up from 38,653 at the end of the previous reported quarter. (NASDAQ:BIIB). Moreover, Fiera Cap has 0.01% invested in Biogen Inc. The company's stock had a trading volume of 1,000,000 shares, compared to its average volume of 1,730,000. About 776,529 shares traded. Discovery Communications, Inc. (NASDAQ:DISCK) has risen 0.32% since February 28, 2017 and is uptrending. It has outperformed by 26.62% the S&P500. Therefore 64% are positive. Canadian Imperial Bank Of Commerce had 29 analyst reports since August 4, 2015 according to SRatingsIntel. Mizuho set a $400.00 price objective on shares of Biogen and gave the company a buy rating in a research report on Monday, November 27th. The rating was maintained by Canaccord Genuity on Thursday, November 2 with "Buy". Sanford C. Bernstein set a $318.00 price target on Biogen and gave the stock a "buy" rating in a report on Tuesday, November 28th. Aegis Capital initiated Facebook, Inc. (NASDAQ:BIIB) for 6,545 shares. On Thursday, January 25 the stock rating was maintained by Cowen & Co with "Buy". As per Wednesday, January 27, the company rating was maintained by Argus Research. Winch Advisory Services Llc acquired 5,198 shares as Apple Inc Com (AAPL)'s stock rose 12.78%. Finally, Robert W. Baird reaffirmed a "hold" rating on shares of Biogen in a research note on Thursday, January 25th. The stock has "Underperform" rating by Credit Suisse on Thursday, August 27. As per Monday, June 19, the company rating was upgraded by UBS.

Since August 28, 2017, it had 0 buys, and 5 insider sales for $26.38 million activity. The insider Sandrock Alfred sold 743 shares worth $216,956. Over the last ninety days, insiders purchased 31,560 shares of company stock worth $10,020,858 and sold 7,869 shares worth $2,526,187. On Friday, February 16 the insider TRAVIS TRACEY THOMAS sold $700,550. (NASDAQ:BIIB) or 5,832 shares. The company has its outstanding shares of 211.4 Million. Asset Mgmt One Ltd owns 362,566 shares for 0.27% of their portfolio. It also reduced its holding in Magna Inte (NYSE:MGA) by 7,900 shares in the quarter, leaving it with 99,520 shares, and cut its stake in Reinsuranc (NYSE:RGA). Its up 0.25, from 0.88 in 2017Q2. It turned negative, as 53 investors sold FB shares while 618 reduced holdings. Culbertson A N & holds 820 shares. Grimes & Co Inc reported 3,167 shares. The stock decreased 0.08% or $0.05 during the last trading session, reaching $63.57. Fayez Sarofim And owns 2.64% invested in Facebook, Inc. Sands Cap Mgmt Limited Company holds 1.13% or 1.21M shares in its portfolio. Tyvor Capital Llc, a Illinois-based fund reported 236,018 shares. Nfc Ltd Limited Liability Company stated it has 0.14% in Apple Inc. (NASDAQ:AAPL). Noesis Cap Mangement Corp has 1% invested in Apple Inc. Swiss State Bank has 54,400 shares for 0% of their portfolio. Amp Invsts Limited holds 99,641 shares. Spears Abacus Advisors Llc reported 0.27% stake.

More notable recent Biogen Inc.

TheStreet downgraded shares of Biogen (NASDAQ:BIIB) from a b- rating to a c+ rating in a research report report published on Thursday morning. Therefore 73% are positive. Michael Kors Holdings Ltd had 121 analyst reports since July 21, 2015 according to SRatingsIntel. (NASDAQ:FIVE) on Wednesday, October 26 with "Buy" rating. On Friday, October 14 the stock rating was upgraded by Chardan Capital Markets to "Neutral". The firm has "Buy" rating by Jefferies given on Tuesday, October 10. The rating was maintained by Wedbush on Wednesday, October 19 with "Outperform". First Analysis upgraded Cambrex Corporation (NYSE:CBM) on Monday, November 7 to "Overweight" rating. Wells Fargo & Company Mn holds 975,992 shares or 0.09% of its portfolio. As per Thursday, September 21, the company rating was downgraded by Raymond James. The stock has "Buy" rating by Stifel Nicolaus on Friday, September 25. BMO Capital Markets maintained it with "Outperform" rating and $386 target in Monday, November 6 report. Recently, investment analysts covering the stock have updated the mean rating to 2.25. (NASDAQ:PCRX) to report earnings on March, 7. During the same period in the prior year, the business posted $5.04 EPS. The 1 year EPS growth rate is 18.80%. Biogen's revenue for the quarter was up 15.1% on a year-over-year basis.

Chancellor Sharp presents Fisher with National Championship plaque
Fisher will get his first on-field look at his new program beginning on March 20, when the Aggies open spring practice. In fact, this is technically an FCS - the actual Division I - national title trophy.

National Hockey League trade deadline: Jets acquire center Paul Stastny from Blues
The Sabres received a conditional first-round pick in 2019, a conditional fourth-round pick and prospect Dan O'Regan for Kane. It's been challenging to fairly evaluate Stastny's abilities as an on-ice contributor during his time in St.

'Shark Tank' judges rejected the startup Amazon just acquired for $1 billion
Adding Ring's facial-recognition service could make it easier and faster to give those visitors access. Being an Amazon product, the new Ring Doorbells will be using Amazon's Alexa voice assistant .

Investors sentiment increased to 1.1 in Q3 2017. It is positive, as 35 investors sold KORS shares while 122 reduced holdings. 92 funds opened positions while 249 raised stakes. 181.16 million shares or 0.28% more from 180.66 million shares in 2017Q2 were reported. Net profit margin of Biogen Inc. (NASDAQ:BIIB). Moreover, Ig Inv Ltd has 0.13% invested in Biogen Inc. Security Natl Tru Com has invested 0% of its portfolio in Cummins Inc. (NASDAQ:BIIB). Geode Ltd Com accumulated 0.28% or 2.42M shares. (NASDAQ:BIIB) for 232,061 shares. Stevens Limited Partnership owns 13,635 shares. Pathstone Family Office Limited Com invested 0.11% of its portfolio in Biogen Inc.

Greatmark Investment Partners Inc increased its stake in Biogen Inc (BIIB) by 97.93% based on its latest 2017Q3 regulatory filing with the SEC. 1,641 are held by Gideon Capital Advsr Inc. (NASDAQ:BIIB) or 339,085 shares. Court Place Advisors Lc has invested 1.98% of its portfolio in Biogen Inc. 12,000 shares valued at $618,387 were sold by KLOSK STEVEN M on Friday, September 1.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.